Glucose-6-phosphate dehydrogenase deficiency risk factors: Difference between revisions
No edit summary |
No edit summary |
||
| Line 29: | Line 29: | ||
*Common risk factors in the development of G6PD include: | *Common risk factors in the development of G6PD include: | ||
**Foods such as fava beans in G6PD mutation carriers | **Foods such as fava beans in G6PD mutation carriers | ||
**Medications such as: | **Medications such as: <ref name="pmid29262208">{{cite journal |vauthors=Richardson SR, O'Malley GF |title= |journal= |volume= |issue= |pages= |date= |pmid=29262208 |doi= |url=}}</ref> | ||
***Aspirin | ***Aspirin | ||
***Antimalarials: quinine, primaquine, pamaquine, and chloroquine | ***Antimalarials: quinine, primaquine, pamaquine, and chloroquine | ||
| Line 37: | Line 37: | ||
***Analgesics: phenazopyridine and acetanilide | ***Analgesics: phenazopyridine and acetanilide | ||
***Rasburicase | ***Rasburicase | ||
***Some non-sulfa antibiotics | ***Some non-sulfa antibiotics such as furazolidone, isoniazid, dapsone, nalidixic acid, nitrofurantoin). | ||
***High dose vitamin C | |||
*** | *** | ||
**Bacterial, viral and rickettsial infection | **Bacterial, viral and rickettsial infection | ||
Revision as of 16:52, 14 August 2018
|
Glucose-6-phosphate dehydrogenase deficiency Microchapters |
|
Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glucose-6-phosphate dehydrogenase deficiency risk factors On the Web |
|
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency risk factors |
|
FDA on Glucose-6-phosphate dehydrogenase deficiency risk factors |
|
CDC on Glucose-6-phosphate dehydrogenase deficiency risk factors |
|
Glucose-6-phosphate dehydrogenase deficiency risk factors in the news |
|
Blogs on Glucose-6-phosphate dehydrogenase deficiency risk factors |
|
Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency |
|
Risk calculators and risk factors for Glucose-6-phosphate dehydrogenase deficiency risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
There are no established risk factors for [disease name].
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
Risk Factors
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
Common Risk Factor
- Common risk factors in the development of G6PD include:
- Foods such as fava beans in G6PD mutation carriers
- Medications such as: [1]
- Aspirin
- Antimalarials: quinine, primaquine, pamaquine, and chloroquine
- Sulfonamides: mafenide, sulfanilamide, sulfamethoxazole
- Thiazolesulfone
- Methylene blue
- Analgesics: phenazopyridine and acetanilide
- Rasburicase
- Some non-sulfa antibiotics such as furazolidone, isoniazid, dapsone, nalidixic acid, nitrofurantoin).
- High dose vitamin C
- Bacterial, viral and rickettsial infection
- Some chemicals: Hanna in tattos and hair dyes.[2]
Less Common Risk Factors
- Less common risk factors in the development of G6PD include:
References
- ↑ Richardson SR, O'Malley GF. PMID 29262208. Missing or empty
|title=(help) - ↑ Raupp P, Hassan JA, Varughese M, Kristiansson B (November 2001). "Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency". Arch. Dis. Child. 85 (5): 411–2. PMC 1718961. PMID 11668106.
- ↑ Gellady AM, Greenwood RD (June 1972). "G-6-PD hemolytic anemia complicating diabetic ketoacidosis". J. Pediatr. 80 (6): 1037–8. PMID 4623682.
- ↑ Beaupre SR, Schiffman FJ (June 1994). "Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use". Arch Fam Med. 3 (6): 545–8. PMID 8081534.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [4]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Risk Factors
- Ethnic groups
- African American
- Middle Eastern decent, particularly Kurdish or Sephardic Jewish
- Male
- Family history of the deficiency